Research Topics
| Lindsay F SteadSummaryAffiliation: University of Oxford Country: UK Publications
|
Detail Information
Publications
A systematic review of interventions for preventing tobacco sales to minorsL F Stead
Imperial Cancer Research Fund General Practice Research Group, Department of Primary Health Care, University of Oxford, UK
Tob Control 9:169-76. 2000..To assess the effectiveness of interventions to reduce underage access to tobacco by deterring shopkeepers from making illegal sales...- Updating a systematic review--what difference did it make? Case study of nicotine replacement therapyL F Stead
Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, UK
BMC Med Res Methodol 1:10. 2001..To examine the effect of updating a systematic review of nicotine replacement therapy on its contents and conclusions... - A systematic review of interventions for smokers who contact quitlinesLindsay F Stead
Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, Rosemary Rue Building, Old Road Campus, Headington, Oxford OX3 7LF, UK
Tob Control 16:i3-8. 2007.... 
Telephone counselling for smoking cessationL F Stead
Oxford University, Department of Primary Health Care, Old Road Campus, Headington, Oxford, UK OX3 7LF
Cochrane Database Syst Rev 3:CD002850. 2006..Telephone services can provide information and support for smokers. Counselling may be provided proactively or offered reactively to callers to smoking cessation helplines...
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessationLindsay F Stead
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Cochrane Database Syst Rev 12:CD009670. 2012..Effective pharmacotherapies are available to help people who are trying to stop smoking, but quitting can still be difficult and providing higher levels of behavioural support may increase success rates further...- Nicotine replacement therapy for smoking cessationLindsay F Stead
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Cochrane Database Syst Rev 11:CD000146. 2012.... - Nicotine receptor partial agonists for smoking cessationKate Cahill
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Cochrane Database Syst Rev 4:CD006103. 2012.... - Combined pharmacotherapy and behavioural interventions for smoking cessationLindsay F Stead
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Cochrane Database Syst Rev 10:CD008286. 2012..Combining both treatment approaches is recommended where possible, but the size of the treatment effect with different combinations and in different settings and populations is unclear... - Silver acetate for smoking cessationTim Lancaster
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Cochrane Database Syst Rev 9:CD000191. 2012..It has been marketed in various forms with the aim of extinguishing the urge to smoke, by pairing the urge with an unpleasant stimulus... - Lobeline for smoking cessationLindsay F Stead
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Cochrane Database Syst Rev 2:CD000124. 2012..Lobeline is a partial nicotine agonist, which has been used in a variety of commercially available preparations to help stop smoking... - Prevention of relapse after quitting smoking: a systematic review of trialsTim Lancaster
Department of Primary Health Care, University of Oxford, Headington, England
Arch Intern Med 166:828-35. 2006..We aimed to assess whether interventions designed to prevent relapse after a successful quit attempt reduce the proportion of recent quitters who return to smoking... - Nicotine receptor partial agonists for smoking cessationKate Cahill
Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
Cochrane Database Syst Rev 2:CD006103. 2011..The first trial reports of varenicline were released in 2006, and further trials have now been published or are currently underway... - Nicotine receptor partial agonists for smoking cessationKate Cahill
Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
Cochrane Database Syst Rev 12:CD006103. 2010..The first trial reports of varenicline were released in 2006, and further trials have now been published or are currently underway... - Tobacco addictionDorothy K Hatsukami
University of Minnesota, Comprehensive Cancer Center and Psychiatry, Minneapolis, Minnesota, USA
Lancet 371:2027-38. 2008..The future of treatment resides in improvement in patient matching to treatment, combination or novel drugs, and viewing nicotine addiction as a chronic disorder that might need long-term treatment... - Nortriptyline for smoking cessation: a reviewJohn R Hughes
Departments of Psychiatry, Psychology, and Family Practice, University of Vermont, Burlington, VT 05401, USA
Nicotine Tob Res 7:491-9. 2005..Until further studies can verify a low incidence of significant adverse events, nortriptyline should be a second-line treatment for smoking cessation... - Effectiveness of over-the-counter nicotine replacement therapyLindsay F Stead
JAMA 288:3109-10; author reply 3110. 2002 - Smoking cessation interventions for hospitalized smokers: a systematic reviewNancy A Rigotti
Tobacco Research and Treatment Center, Massachusetts General Hospital, 50 Staniford St, Room 914, Boston, MA 02114, USA
Arch Intern Med 168:1950-60. 2008..Providing smoking cessation advice, counseling, or medication is now a quality-of-care measure for US hospitals. We assessed the effectiveness of smoking cessation interventions initiated during a hospital stay...